ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $211,000 | +15.3% | 51,395 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $183,000 | +346.3% | 51,395 | +356.6% | 0.00% | – |
| Q3 2021 | $41,000 | -16.3% | 11,255 | 0.0% | 0.00% | – |
| Q2 2021 | $49,000 | +6.5% | 11,255 | 0.0% | 0.00% | – |
| Q1 2021 | $46,000 | +2.2% | 11,255 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | +50.0% | 11,255 | 0.0% | 0.00% | – |
| Q3 2020 | $30,000 | -3.2% | 11,255 | 0.0% | 0.00% | – |
| Q2 2020 | $31,000 | +14.8% | 11,255 | 0.0% | 0.00% | – |
| Q1 2020 | $27,000 | -49.1% | 11,255 | 0.0% | 0.00% | – |
| Q4 2019 | $53,000 | +39.5% | 11,255 | 0.0% | 0.00% | – |
| Q3 2019 | $38,000 | +2.7% | 11,255 | 0.0% | 0.00% | – |
| Q2 2019 | $37,000 | +8.8% | 11,255 | 0.0% | 0.00% | – |
| Q1 2019 | $34,000 | +9.7% | 11,255 | 0.0% | 0.00% | – |
| Q4 2018 | $31,000 | – | 11,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |